Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01064765 · ClinicalTrials.gov registry record

ACT-HF: Attention, Cognition and Self-Management in Heart Failure

A clinical trial, sponsored by University of Chicago.

Completed
Registry status
72
Enrollment target

NCT01064765: Completed study, sponsored by University of Chicago.

NCT01064765 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01064765 has completed, sponsored by University of Chicago.

COMPLETED
Registry status
72 participants
Enrollment target

Study Summary

This study is designed to determine if a relationship exists between problems with memory, attention, learning, insight and executive function and self management in heart failure.

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2008-09
Est. Completion 2011-03
University of Chicago

796 total trials

What the finished NCT01064765 record still lists

NCT01064765 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01064765 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01064765 about?

NCT01064765 is a clinical study titled "ACT-HF: Attention, Cognition and Self-Management in Heart Failure". This study is designed to determine if a relationship exists between problems with memory, attention, learning, insight and executive function and self management in heart failure.

What is the current status of trial NCT01064765?

This trial is currently completed. The enrollment target is 72 participants. The study started on 2008-09. Estimated completion is 2011-03.

Who is sponsoring clinical trial NCT01064765?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01064765, the US trial registry maintained by the National Library of Medicine. NCT01064765 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.